NCT03322384
- Conditions
- Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Clinical trial condition
Advanced Solid Tumors
Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.
609 public trials
183 recruiting studies
Advanced Solid Tumors trial results
NCT00999401
- Conditions
- Advanced Solid Tumors
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT03931681
- Conditions
- Advanced Solid Tumors
- Locations
-
- University of Colorado Cancer Center Aurora, Colorado, United States
NCT03348514
- Conditions
- Advanced Solid Tumors
- Locations
-
- Sarah Cannon Research Institute Denver, Colorado, United States
- Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- Stephenson Cancer Center Oklahoma City, Oklahoma, United States
NCT03319459
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
- Locations
-
- UCSD Moores Cancer Center San Diego, California, United States
- University of Minnesota Minneapolis, Minnesota, United States
- The Ohio State University James Cancer Hospital Columbus, Ohio, United States
- Baylor Scott & White Research Institute Dallas, Texas, United States
NCT03497429
- Conditions
- Advanced Solid Tumors
- Locations
-
- National Cancer Center Hospital Chuo-ku, Tokyo, Japan
NCT05086822
- Conditions
- Advanced Solid Tumors
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Completed
A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors
NCT05086848
- Conditions
- Advanced Solid Tumors
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Completed
Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors
NCT03895684
- Conditions
- Advanced Solid Tumors
- Locations
-
- HonorHealth Scottsdale, Arizona, United States
- Sarcoma Oncology Research Center Santa Monica, California, United States
Completed
Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors
NCT01910597
- Conditions
- Advanced Solid Tumors
- Locations
-
- Songklanagarind Hospital, Prince of Songkla University Hat Yai, Changwat Songkhla, Thailand